A wide range of endogenous substances, associated with the study of metabolomicsand determination of biomarkers, can be detected also.

Using the existing installed base of laboratory instrumentation, together with established and validated analytical procedures, this exhaled breath-based biomatrix platform called ExaBreath® (EB), is transforming drug detection, health monitoring and medical diagnostics for: